Clinical trial
A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat…
NCT00109070 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00109070 |
|---|---|
| Title | A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer |
| Official title | A Phase III, Multicenter, Randomized, Active-Controlled Clinical Trial to Evaluate the Efficacy and Safety of rhuMAb VEGF (Bevacizumab) in Combination With Standard Chemotherapy in Subjects With Metastatic Colorectal Cancer |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Avastin (bevacizumab) |
| Start date | Sep 1, 2000 |
| Completion | Apr 1, 2003 |
| First posted | Apr 25, 2005 |
| Last update posted | Jun 21, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: